These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 18796331

  • 1. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A, Handa H, Mao G, Panyam J.
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [Abstract] [Full Text] [Related]

  • 2. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
    Khdair A, Gerard B, Handa H, Mao G, Shekhar MP, Panyam J.
    Mol Pharm; 2008 Feb; 5(5):795-807. PubMed ID: 18646775
    [Abstract] [Full Text] [Related]

  • 3. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
    Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MP, Panyam J.
    Mol Pharm; 2007 Feb; 4(5):730-8. PubMed ID: 17705442
    [Abstract] [Full Text] [Related]

  • 4. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.
    Khdair A, Chen D, Patil Y, Ma L, Dou QP, Shekhar MP, Panyam J.
    J Control Release; 2010 Jan 25; 141(2):137-44. PubMed ID: 19751777
    [Abstract] [Full Text] [Related]

  • 5. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles.
    Usacheva M, Swaminathan SK, Kirtane AR, Panyam J.
    Mol Pharm; 2014 Sep 02; 11(9):3186-95. PubMed ID: 25061685
    [Abstract] [Full Text] [Related]

  • 6. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y, Sadhukha T, Ma L, Panyam J.
    J Control Release; 2009 May 21; 136(1):21-9. PubMed ID: 19331851
    [Abstract] [Full Text] [Related]

  • 7. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
    Abulrob AN, Mason M, Bryce R, Gumbleton M.
    J Drug Target; 2000 May 21; 8(4):247-56. PubMed ID: 11144235
    [Abstract] [Full Text] [Related]

  • 8. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 21; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 9. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY.
    J Pharmacol Exp Ther; 2006 Jun 21; 317(3):1372-81. PubMed ID: 16547167
    [Abstract] [Full Text] [Related]

  • 10. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
    Chavanpatil MD, Khdair A, Panyam J.
    Pharm Res; 2007 Apr 21; 24(4):803-10. PubMed ID: 17318416
    [Abstract] [Full Text] [Related]

  • 11. Cellular uptake and photodynamic activity of protein nanocages containing methylene blue photosensitizing drug.
    Yan F, Zhang Y, Kim KS, Yuan HK, Vo-Dinh T.
    Photochem Photobiol; 2010 Apr 21; 86(3):662-6. PubMed ID: 20132513
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD, Patil Y, Panyam J.
    Int J Pharm; 2006 Aug 31; 320(1-2):150-6. PubMed ID: 16713148
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL, Bendayan R, Rauth AM, Wu XY.
    J Control Release; 2006 Dec 01; 116(3):275-84. PubMed ID: 17097178
    [Abstract] [Full Text] [Related]

  • 14. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H.
    Int J Pharm; 2007 Feb 01; 329(1-2):94-102. PubMed ID: 16997518
    [Abstract] [Full Text] [Related]

  • 15. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY.
    Breast Cancer Res Treat; 2010 Jan 01; 119(2):255-69. PubMed ID: 19221875
    [Abstract] [Full Text] [Related]

  • 16. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.
    Cancer Gene Ther; 2009 Jan 01; 16(1):65-72. PubMed ID: 18654608
    [Abstract] [Full Text] [Related]

  • 17. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D, Gao X, Kang T, Feng X, Yao J, Yang M, Jing Y, Zhu Q, Feng J, Chen J.
    Nanoscale; 2016 Feb 07; 8(5):3100-18. PubMed ID: 26785758
    [Abstract] [Full Text] [Related]

  • 18. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X, Morgenstern R, Nyström AM.
    Biomaterials; 2014 Jan 07; 35(4):1227-39. PubMed ID: 24210875
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J, Martin C, Callaghan R.
    Eur J Cancer; 2004 Mar 07; 40(4):594-605. PubMed ID: 14962729
    [Abstract] [Full Text] [Related]

  • 20. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M.
    PLoS One; 2007 Aug 01; 2(8):e693. PubMed ID: 17668070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.